These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 356056)

  • 1. Coronary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with prostacyclin and other prostanoids.
    Hyman AL; Kadowitz PJ; Lands WE; Crawford CG; Fried J; Barton J
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3522-6. PubMed ID: 356056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual pulmonary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with endoperoxides and other prostanoids.
    Hyman AL; Chapnick BM; Kadowitz PJ; Lands WE; Crawford CG; Fried J; Barton J
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5711-5. PubMed ID: 414226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
    Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
    Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardiac effects of prostaglandins and their modification by the prostaglandin antagonist N-0164.
    Allan G; Levi R
    J Pharmacol Exp Ther; 1980 Jul; 214(1):45-9. PubMed ID: 6993659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary vascular responses to prostaglandins.
    Kadowitz PJ; Gruetter CA; Spannhake EW; Hyman AL
    Fed Proc; 1981 May; 40(7):1991-6. PubMed ID: 7014258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin (PGI2) is a weak contractor of coronary arteries of the pig.
    Dusting GJ; Moncada S; Vane JR
    Eur J Pharmacol; 1977 Oct; 45(3):301-4. PubMed ID: 336382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of arachidonic acid and prostaglandin endoperoxides by the guinea pig heart. Formation of RCS and prostacyclin.
    Schrör K; Moncada S; Ubatuba FB; Vane JR
    Eur J Pharmacol; 1978 Jan; 47(1):103-14. PubMed ID: 338313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2.
    Kadowitz PJ; Chapnick BM; Feigen LP; Hyman AL; Nelson PK; Spannhake EW
    J Appl Physiol Respir Environ Exerc Physiol; 1978 Sep; 45(3):408-13. PubMed ID: 359514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular responses to PGI2 (prostacyclin) in the dog.
    Fitzpatrick TM; Alter I; Corey EJ; Ramwell PW; Rose JC; Kot PA
    Circ Res; 1978 Feb; 42(2):192-4. PubMed ID: 340081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of prostacyclin involvement in angiotensin-induced aldosterone secretion in rat adrenal cells.
    Campbell WB; Gomez-Sanchez CE
    Endocrinology; 1985 Jul; 117(1):279-86. PubMed ID: 3924581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of pulmonary vascular responses to arachidonic acid by alterations in physiologic state.
    Hyman AL; Mathe AA; Leslie CA; Matthews CC; Bennett JT; Spannhake EW; Kadowitz PJ
    J Pharmacol Exp Ther; 1978 Nov; 207(2):388-401. PubMed ID: 361946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular actions of arachidonic acid and its metabolites in perfused mesenteric and femoral beds of the dog.
    Dusting GJ; Moncada S; Vane JR
    Eur J Pharmacol; 1978 May; 49(1):65-72. PubMed ID: 350595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal vascular effects of endoperoxide analogs, prostaglandins, and arachidonic acid.
    Feigen LP; Chapnick BM; Flemming JE; Flemming JM; Kadowitz PJ
    Am J Physiol; 1977 Nov; 233(5):H573-9. PubMed ID: 920820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of prostaglandins in peripheral vascular beds.
    Feigen LP
    Fed Proc; 1981 May; 40(7):1987-90. PubMed ID: 7014257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 13, 14-dehydroprostacyclin methyl ester on the feline intestinal vascular bed.
    Paustian PW; Chapnick BM; Feigen LP; Hyman AL; Kadowitz PJ
    Prostaglandins; 1977; 14(6):1141-52. PubMed ID: 341229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of arachidonic acid, bisenoic prostaglandins, and an endoperoxide analog on the canine pulmonary vascular bed.
    Kadowitz PJ; Spannhake EW; Greenberg S; Feigen LP; Hyman A
    Can J Physiol Pharmacol; 1977 Dec; 55(6):1369-77. PubMed ID: 597784
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular responses to an isosterically modified prostaglandin analog in the anesthetized dog.
    Siegl PK; Wenger HC
    Eur J Pharmacol; 1985 Jul; 113(3):305-11. PubMed ID: 3899681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system effects of arachidonic acid, PGE2, PGF2 alpha, PGD2 and PGI2 on gastric secretion in the rat.
    Puurunen J
    Br J Pharmacol; 1983 Oct; 80(2):255-62. PubMed ID: 6360279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hemodynamic effects of prostaglandins in the rat. Evidence for important species variation in renovascular responses.
    Gerber JG; Nies AS
    Circ Res; 1979 Mar; 44(3):406-10. PubMed ID: 367631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential actions of the prostaglandins on the pulmonary vascular bed.
    Kadowitz PJ; Spannhake EW; Levin JL; Hyman AL
    Adv Prostaglandin Thromboxane Res; 1980; 7():731-43. PubMed ID: 6989201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.